The company said the defect affects a subset of its Kappa and Sigma pacemakers, causing them not to respond or [to] run out of battery power.
About 1.7 million of the pacemakers have been implanted since 1997, the company estimates.
Medtronic, Inc., headquartered in Minneapolis, is the world’s leading medical technology company, alleviating pain, restoring health and extending life for people with chronic disease. Medtronic, Inc. (NYSE: MDT) today announced financial results for its fiscal year and fourth quarter ended April 24, 2009. Medtronic recorded fiscal year 2009 revenue of $14.599 billion, an 8 percent increase over the $13.515 billion in fiscal year 2008.